BioNTech Results Presentation Deck slide image

BioNTech Results Presentation Deck

Second Quarter 2020 Financial Results (unaudited) - Profit and Loss (in millions) ¹ Revenues resulting from collaboration and license agreements Revenues from other sales transactions Total revenues 25 Cost of sales Gross profit Research and development expenses Sales and marketing expenses General and administrative expenses Other operating income less expenses Finance income less expenses Income taxes Loss for the period 1 Due to rounding, numbers presented may not add up precisely to the totals. Three months ended June 30, 2019 € 20.1 5.7 € 25.8 2020 € 32.6 9.2 € 41.8 (5.7) € 36.1 (95.2) (3.0) (18.8) 0.0 (9.6) 2.2 € (88.3) (5.5) € 20.3 (53.4) (0.7) (14.6) 0.5 (2.2) 0.0 € (50.1) Six months ended June 30, 2019 € 42.0 9.9 € 51.9 2020 € 53.7 15.7 € 69.4 (11.5) € 57.9 (160.3) (3.5) (34.6) 0.3 (3.7) 2.2 € (141.7) (8.7) € 43.2 (110.6) (1.2) (23.9) 0.8 0.9 0.0 € (90.8) BIONTECH
View entire presentation